Back

Assessing feasibility and effectiveness of point-of-care limited HPV genotype tests in cervical cancer screening: a modelling study

2025-03-13 sexual and reproductive health Title + abstract only
View on medRxiv
Show abstract

BackgroundCervical cancer (CaCx) remains a significant cause of morbidity and mortality, especially among women in sub-Saharan Africa, where only 15% of women have undergone screening. To address these substantial screening gaps, the WHO recommends human papillomavirus (HPV) DNA detection as the primary screening method. One strategy to improve screening coverage is the use of limited HPV genotype target tests which can be offered as true point-of-care (POC) tests. However, understanding the con...

Predicted journal destinations